NanoViricides Inc. | |
Stock Exchange | NYSE |
EPS |
$0.11 |
Market Cap |
$18.42 M |
Shares Outstanding |
76.74 M |
Public Float |
47.23 M |
Address |
1 Controls Drive Shelton Connecticut 06484 United States |
Employees | - |
Website | http://www.nanoviricides.com |
Updated | 07/08/2019 |
NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. |